Skip to main content
Fig. 6 | Hereditas

Fig. 6

From: Integrated multi-omics analysis and machine learning refine molecular subtypes and clinical outcome for hepatocellular carcinoma

Fig. 6

Relationship between CMLBS model and immune microenvironment. (A). The distribution of TME immune cell type signatures between high- and low-CMLBS patients. (B). The distribution of immune suppression signatures between high- and low-CMLBS patients. (C). The distribution of immune exclusion signatures between high- and low-CMLBS patients. (D). The distribution of immunotherapy biomarkers between high- and low-CMLBS patients. (E). The distribution of TMB between high- and low-CMLBS patients. (F). The distribution of TNB between high- and low-CMLBS patients. (G). The distribution of M1 macrophages between high- and low-CMLBS patients. (H). The relationship between CMLBS and M1 macrophages. (I-K). Survival analysis combined CMLBS with TMB, TNB, and M1 macrophages

Back to article page

Hereditas

ISSN: 1601-5223

Contact us